BF Biosciences Limited (PSX:BFBIO)
167.26
0.00 (0.00%)
At close: Apr 3, 2025
BF Biosciences Cash Flow Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 |
Net Income | 428.05 | 385.41 | 149.05 | 306.98 | 607.99 | 47.11 | Upgrade
|
Depreciation & Amortization | 66.86 | 36.12 | 34.33 | 28 | 23 | 22 | Upgrade
|
Loss (Gain) From Sale of Assets | -0.48 | -2.13 | -1.06 | - | - | - | Upgrade
|
Loss (Gain) From Sale of Investments | -33.67 | -0.21 | -8.93 | - | - | - | Upgrade
|
Other Operating Activities | 181.19 | 305.49 | 32.12 | -156.98 | -60.99 | -89.11 | Upgrade
|
Change in Accounts Receivable | -173.13 | -110.82 | -41.1 | - | - | - | Upgrade
|
Change in Inventory | -598.95 | -41.57 | -445.69 | - | - | - | Upgrade
|
Change in Accounts Payable | 664.47 | 196.75 | -5.94 | - | - | - | Upgrade
|
Change in Unearned Revenue | -16.37 | 19.75 | -17.78 | - | - | - | Upgrade
|
Change in Other Net Operating Assets | 29.54 | -127.09 | 108.94 | - | - | - | Upgrade
|
Operating Cash Flow | 556.54 | 661.7 | -196.07 | 178 | 570 | -20 | Upgrade
|
Operating Cash Flow Growth | - | - | - | -68.77% | - | - | Upgrade
|
Capital Expenditures | -272.76 | -143.13 | -1,968 | -1,130 | -941 | -22 | Upgrade
|
Sale of Property, Plant & Equipment | 4.57 | 4.4 | 1.06 | - | - | - | Upgrade
|
Sale (Purchase) of Intangibles | - | - | -1.66 | - | - | - | Upgrade
|
Investment in Securities | -1,728 | 108.58 | 1,161 | - | - | - | Upgrade
|
Other Investing Activities | 29.92 | 19.34 | 83.4 | -333 | -399 | 17 | Upgrade
|
Investing Cash Flow | -1,966 | -10.81 | -724.44 | -1,463 | -1,340 | -5 | Upgrade
|
Long-Term Debt Issued | - | - | 811.02 | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -321.36 | -50.5 | - | - | - | Upgrade
|
Net Debt Issued (Repaid) | -293.06 | -321.36 | 760.52 | - | - | - | Upgrade
|
Other Financing Activities | -142.85 | -161.52 | -120.28 | 925 | 1,162 | 6 | Upgrade
|
Financing Cash Flow | 1,419 | -482.88 | 640.24 | 925 | 1,162 | 6 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | - | - | 1 | 1 | - | Upgrade
|
Net Cash Flow | 9.37 | 168.02 | -280.27 | -359 | 393 | -19 | Upgrade
|
Free Cash Flow | 283.77 | 518.57 | -2,164 | -952 | -371 | -42 | Upgrade
|
Free Cash Flow Margin | 6.28% | 14.17% | -119.61% | -62.60% | -21.14% | -6.69% | Upgrade
|
Free Cash Flow Per Share | 4.14 | 8.19 | -34.17 | -15.03 | -5.86 | -0.66 | Upgrade
|
Cash Interest Paid | 142.85 | 161.52 | 120.28 | - | - | - | Upgrade
|
Cash Income Tax Paid | 210.76 | 51.39 | 73.4 | - | - | - | Upgrade
|
Levered Free Cash Flow | - | 400.58 | -2,306 | -834 | -670.45 | 28.13 | Upgrade
|
Unlevered Free Cash Flow | - | 401.52 | -2,306 | -792.99 | -654.66 | 28.86 | Upgrade
|
Change in Net Working Capital | - | -64.06 | 538.33 | -157.62 | 112.39 | -19.6 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.